Article
Bias and Inconsistency in the Estimation of Tumour Mutation Burden
2022-05-25
Abstract excerpt
<h4>Background: </h4> Tumour mutation burden (TMB), defined as the number of somatic mutations per megabase within the sequenced region in the tumour sample, has been used as a biomarker for predicting response to immune therapy. Several studies have been conducted to assess the utility of TMB for various cancer types; however, methods to measure TMB have not been adequately evaluated. In this study, we identified...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c9af6ef7-cdec-5aee-8682-1c12842a65d1
- DOI
- 10.21203/rs.3.rs-1637632/v1
